STOCK TITAN

The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction

(Moderate)
(Negative)
Tags

Key Terms

ipo financial
An initial public offering (IPO) is the process by which a private company sells its shares to the public for the first time, making its ownership available on the stock market. This allows the company to raise money from a wide range of investors to fund growth or other goals. For investors, an IPO offers a chance to buy into a company early in its public journey, potentially benefiting if the company grows in value.
View in glossary
chapter 11 bankruptcy protection regulatory
Chapter 11 bankruptcy protection is a legal process that lets a financially troubled company pause creditor actions and reorganize its debts and operations under court oversight, often continuing to operate while it creates a plan to pay creditors. For investors, it matters because the company’s existing shares and debt can be drastically reduced or reshaped during the restructuring, so equity may be wiped out or diluted while creditors’ claims are prioritized—think of it as a court-ordered time‑out to redraw the company’s financial map.
proxy statement regulatory
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
View in glossary
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

HOUSTON--(BUSINESS WIRE)-- Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group” or “we”), who collectively own approximately 7.7% of the outstanding shares of Seer, Inc. (NASDAQ: SEER) (“Seer” or the “Company”), today issued the following statement:

Source: FactSet; total stockholder return graph from December 4, 2020 through April 10, 2026, the trading day immediately prior to the Radoff-JEC Group’s submission of its initial non-binding proposal to acquire the Company.

Source: FactSet; total stockholder return graph from December 4, 2020 through April 10, 2026, the trading day immediately prior to the Radoff-JEC Group’s submission of its initial non-binding proposal to acquire the Company.

“When Seer filed its proxy statement, the Board issued a 4,000-word letter to stockholders that we believe was a collection of inaccurate and misleading statements. In fact, the letter ended with the claim that Seer has the right Board and the right strategy.

Seer’s share price is down 97% since its IPO in December of 2020.1 If Seer had the right Board and the right strategy, would the share price be down 97% over the past five and a half years?

We believe change at Seer is urgently needed. The 97% share price decline supports that conclusion. And the fact that Seer Chair and CEO Omid Farokhzad, M.D. has consistently destroyed stockholder value across numerous companies adds to our view that change is urgently needed.”

Chairman and CEO Farokhzad: A Specialist in Failure

Company

Investor Outcome

Seer

Share price declined 97.0% since going public in 2020.2

BIND Therapeutics, Inc.

Filed for Chapter 11 bankruptcy protection.

Selecta Biosciences, Inc.

Share price declined 93.7% between its IPO and its merger with Cartesian Therapeutics.3

Tarveda Therapeutics, Inc.

Liquidated under a court-supervised assignment of assets.

Senti Biosciences Holdings, Inc.

Share price is down 98.5% since its public listing in 2022.4

More Than $1 Billion in Investor Capital Destroyed

The Radoff-JEC Group is seeking stockholder support to elect three new independent, qualified directors – Howard H. Berman, Ph.D., Joshua S. Horowitz and Luis E. Rinaldini – to SEER’s Board at the Annual Meeting of Stockholders on July 28, 2026.

***

Vote FOR the Radoff-JEC Group’s Nominees TODAY to Prevent Further Value Destruction

Do NOT Vote for Omid Farokhzad, M.D., Terrance McGuire or Dipchand (Deep) Nishar.

Questions about how to vote? Contact (888) 368-0379 or info@saratogaproxy.com.

Visit www.SaratogaProxy.com/SEER to learn more.

***

1 Share price decline from December 4, 2020 through April 10, 2026, the trading day immediately prior to the Radoff-JEC Group’s submission of its initial non-binding proposal to acquire the Company.

2 Ibid.

3 Share price decline from June 22, 2016 through November 13, 2023.

4 Share price decline from June 9, 2022 through June 12, 2026.

 

Greg Lempel
greg@fondrenlp.com

or

Saratoga Proxy Consulting LLC
John Ferguson / Joseph Mills, 212-257-1311
info@saratogaproxy.com

Source: On Behalf of The Radoff-JEC Group